us pfizer lung cancer study 031110 Minneapolis Star Tribune "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer ends study on potential lung cancer drug FederalNewsRadio.com "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
OXiGENE to secure $7.5 million in financing Trading Markets (press release) ... including its ongoing trials of Zybrestat in non-small cell lung cancer and of OXi4503 trials in solid tumors, as well as to continue its programs in ...
Pfizer ends study on potential lung cancer drug Tuscaloosa News (subscription) "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer ends study on potential lung cancer drug Bismarck Tribune "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer ends study on potential lung cancer drug Fort Wayne Journal Gazette "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer Says Two Cancer Drugs Fail in Clinical Trials BusinessWeek The study was evaluating figitumumab for treatment of non- adenocarcinoma non-small cell lung cancer. About 219500 new cases of lung cancer were reported in ...
Pfizer Says Two Cancer Drugs Fail in Clinical Trials Bloomberg The study was evaluating figitumumab for treatment of non- adenocarcinoma non-small cell lung cancer. About 219500 new cases of lung cancer were reported in ...
Roche's Avastin Misses Prostrate-Cancer Goal Wall Street Journal Avastin, an antibody, is approved in the US and Europe for the treatment of advanced stages of colorectal cancer, breast cancer, non-small cell lung cancer ...
Pfizer Ends Study On Potential Lung Cancer Drug CBS News "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer ends study on potential lung cancer drug Atlanta Journal Constitution "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Market Report -- In Play (PFE) MSN Money Pfizer discontinues a Phase 3 study Of figitumumab in previously treated patients with advanced non-small cell lung cancer Co announced today the ...
